N-terminal Stretch Arg2, Arg3, Arg4 and Arg5 of Human Lactoferrin is Essential for Binding to Heparin, Bacterial Lipopolysaccharide, Human Lysozyme and DNA
Overview
Affiliations
Human lactoferrin (hLF), a protein involved in host defence against infection and excessive inflammation, interacts with heparin, the lipid A moiety of bacterial lipopolysaccharide, human lysozyme (hLZ) and DNA. To determine which region of the molecule is important in these interactions, solid-phase ligand binding assays were performed with hLF from human milk (natural hLF) and N-terminally deleted hLF variants. Iron-saturated and natural hLF bound equally well to heparin, lipid A, hLZ and DNA. Natural hLF lacking the first two N-terminal amino acids (Gly1-Arg2) showed reactivities of one-half, two-thirds, one-third and one-third towards heparin, lipid A, hLZ and DNA respectively compared with N-terminally intact hLF. A lack of the first three residues (Gly1-Arg2-Arg3) decreased binding to the same ligands to one-eighth, one-quarter, one-twentieth and one-seventeenth respectively. No binding occurred with a mutant lacking the first five residues (Gly1-Arg2-Arg3-Arg4-Arg5). An anti-hLF monoclonal antibody (E11) that reacts to an N-lobe epitope including Arg5 completely blocked hLF-ligand interaction. These results show that the N-terminal stretch of four consecutive arginine residues, Arg2-Arg3-Arg4-Arg5, has a decisive role in the interaction of hLF with heparin, lipid A, hLZ and DNA. The role of limited N-terminal proteolysis of hLF in its anti-infective and anti-inflammatory properties is discussed.
Vllahu M, Voli A, Licursi V, Zagami C, DAmore A, Traulsen J Gut Microbes. 2024; 16(1):2390680.
PMID: 39244776 PMC: 11382725. DOI: 10.1080/19490976.2024.2390680.
Babulic P, Cehlar O, Ondrovicova G, Moskalets T, Skrabana R, Leksa V Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204126 PMC: 11357225. DOI: 10.3390/ph17081021.
Biji C, Balde A, Nazeer R Inflamm Res. 2024; 73(7):1203-1221.
PMID: 38769154 DOI: 10.1007/s00011-024-01893-6.
Ramirez-Sanchez D, Canizalez-Roman A, Leon-Sicairos N, Perez Martinez G Food Sci Nutr. 2024; 12(5):3516-3528.
PMID: 38726451 PMC: 11077203. DOI: 10.1002/fsn3.4020.
Lactoferrins in Their Interactions with Molecular Targets: A Structure-Based Overview.
Piacentini R, Boffi A, Milanetti E Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543184 PMC: 10974892. DOI: 10.3390/ph17030398.